(All fields required)
Please enter a valid email.
Please enter your name.
What is : (So we know you are human.)
Please supply the correct answer.
research focuses on alveolar fibroblasts during septation and bronchiolar
fibrosis after epithelial injury. Our projects strive to understand the
cellular and molecular mechanisms related to the pathology of lung diseases,
like bronchopulmonary dysplasia (BPD), emphysema, chronic obstructive pulmonary
disease (COPD) and bronchiolitis obliterans (BOS). We use state of the art
transgenic mouse models to provide novel and innovative tools to enable studies
of complex molecular pathways and lineage relationships, in lung development
and diseases. Jenna Green established immunofluorescence staining protocols for
adult mouse lung that allow 3d high resolution confocal imaging.
Our histological approach is complemented by sophisticated flow cytometry to
identify subpopulations of pulmonary fibroblasts, which was established by Leiling
Chen, PhD. We have
two major focuses in the lab:
Read about our work to find out what cellular and molecular mechanisms are important to regrow lung.
We are working to better understand the pathogenesis of the loss of epithelial integrity and subsequent peribronchiolar fibrosis to help improve therapies for lung disorders.
Dr. Perl was seminal in establishing the conditional mouse technology to regulate gene activation and in activation in the lung epithelium using the tetracycline inducible gene regulation.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2016 Cincinnati Children's Hospital Medical Center. All rights reserved.